Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Ascendis Pharma A/S | ASND | 225.16K | $60.05M |
Krystal Biotech, Inc. | KRYS | 481.31K | $178.89M |
Immunocore Holdings plc | IMCR | 484.78K | $15.39M |
Alkermes plc | ALKS | 700.65K | $36.71M |
Tarsus Pharmaceuticals, Inc. | TARS | 728.64K | $45.86M |
Palvella Therapeutics, Inc. | PVLA | 882.4K | $134.85M |
Monte Rosa Therapeutics, Inc. | GLUE | 1M | $24.2M |
Relay Therapeutics, Inc. | RLAY | 1.02M | $19M |
Kailera Therapeutics, Inc. | KLRA | 1.1M | $24.23M |
Cytokinetics, Incorporated | CYTK | 1.16M | $98.81M |
Disc Medicine, Inc. | IRON | 1.35M | $99.09M |
ACADIA Pharmaceuticals Inc. | ACAD | 1.44M | $36.39M |
BridgeBio Pharma, Inc. | BBIO | 1.55M | $115.31M |
Design Therapeutics, Inc. | DSGN | 1.81M | $26.19M |
Applied Aerospace & Defense, Inc. | AADX | 1.92M | $52.57M |
Evolus, Inc. | EOLS | 2.63M | $18.26M |
Dyne Therapeutics, Inc. | DYN | 3.15M | $70.03M |
BioCryst Pharmaceuticals, Inc. | BCRX | 4.01M | $40.09M |
Aclaris Therapeutics, Inc. | ACRS | 4.93M | $26.06M |
MannKind Corporation | MNKD | 6.6M | $28.12M |